Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent. - Wikidata - awgldk - TriplyDB

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

http://www.wikidata.org/entity/Q34014651

about

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease L-type calcium channels as drug targets in CNS disorders Post-transcriptional modifications and "Calmodulation" of voltage-gated calcium channel function: Reflections by two collaborators of David T Yue Regulation of aldosterone secretion by Cav1.3.Similar molecular determinants on Rem mediate two distinct modes of inhibition of CaV1.2 channels.Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?Cav1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells.Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.

P2860

Q26781422-C5655CDD-6269-4D78-81C1-F1379F92AC55 Q28074143-859792CC-8519-4A69-B13F-9AA71430A04D Q28081812-53B7FBD7-2803-45DA-B10C-2F797359D9A2 Q36714856-143D7881-5A8A-4B2E-A257-272254A86799 Q36926861-2061B404-0806-407E-B289-AFBBE74542E8 Q37183263-AD78F6F6-742A-4F06-AA4A-EC6996EDF4C6 Q38475657-3E42D19B-2E2F-4991-A18C-62CB8A76BD52 Q38475669-6BB1F22C-E8B7-42D4-971D-BF0427B16079 Q38810096-BC10AC4F-1B81-49DA-83B9-F196E3D87F1F

P2860

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

http://www.wikidata.org/entity/Q34014651

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@ast

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@en

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@nl

type

label

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@ast

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@en

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@nl

prefLabel

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@ast

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@en

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@nl

P1433

Q34014651-8E2EF095-3EF9-4F69-8740-7B50994E1046

P1476

Q34014651-A9F69DA6-64B7-4588-BA7C-A35F357ECFEB

P2093

Q34014651-177B7CDC-67E8-4ABD-8797-2D10219F2179

Q34014651-4571B0C2-0634-43F7-BC86-41CBECA49646

Q34014651-46B2908F-F7DB-44C4-847D-D4F06F451BC3

Q34014651-6AB5FC41-10EA-48B6-9702-9DDDDF7958C2

P2860

Q34014651-1B1D287B-DAC1-407F-9D64-D3D819FD160C

Q34014651-2983D84F-050D-4441-B1E0-78C8E1E5FD50

Q34014651-3C8424FE-705C-46C0-B9C1-3E066591F19B

Q34014651-51597207-4090-476D-BC9C-2D4A225D5E60

Q34014651-5324AEC7-EE4E-42D1-9679-E8400F909505

Q34014651-8EFA5BB0-A5B3-401A-A42C-03F609E3FC12

Q34014651-9D7F317F-DE2D-4F14-AD3A-CEA0E2EEC9AB

Q34014651-AB1AA3D0-68C3-4996-A622-DDC2297D0959

Q34014651-BC4E8D07-D577-4E06-A7DA-2C1451FF912E

Q34014651-E778CA06-B18B-4FFE-9C9D-3AC095438880

P2888

Q34014651-FF2735C4-3368-4AC6-9E97-A9B3A20C645C

P304

Q34014651-797AF071-F335-4944-A869-114446A5C9F4

P31

Q34014651-C5E1FA7B-BC49-4708-AD54-1DCB4D8B5D14

P356

Q34014651-AACAD42E-5EF8-4C7C-A85D-3562BD81D77B

P407

Q34014651-2667B7C7-D105-4AE9-A349-E2597298D3C7

P478

Q34014651-F4864947-C935-499D-B10D-470B3A3449A1

P50

Q34014651-B5E01BEF-B36E-483C-9CA8-C9C6E6959525

Q34014651-C87B9702-DC31-4DD0-80A5-1C0B43F9F59A

P577

Q34014651-EBFF39A5-9827-4757-96B7-F23135B46383

P5875

Q34014651-BADB0DA0-FE56-4F9E-8EDC-8A49E162EE7F

P6179

Q34014651-EE1F2546-383D-40E7-829F-B6DFC3BAF603

P698

Q34014651-247E49F8-05C0-45AA-B296-195FF7BD2251

P932

Q34014651-ED65CBB3-1CC0-425E-93E2-92384C47E65F

P356

P1433

Nature Communications

P1476

Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.

@en

P2093

Dejie Yu

http://www.w3.org/2001/XMLSchema#string

Jing Zhai

http://www.w3.org/2001/XMLSchema#string

Tuck Wah Soong

http://www.w3.org/2001/XMLSchema#string

Yulin Lam

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease: from monogenic forms to genetic susceptibility factors

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines

L-type calcium channel blockers and Parkinson disease in Denmark.

Signature combinatorial splicing profiles of rat cardiac- and smooth-muscle Cav1.2 channels with distinct biophysical properties.

Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels

Structural determinants of CaV1.3 L-type calcium channel gating.

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.

C-terminal alternative splicing of CaV1.3 channels distinctively modulates their dihydropyridine sensitivity.

P2888

P304

4481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS5481

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264201700

http://www.w3.org/2001/XMLSchema#string

P6179

1016674252

http://www.w3.org/2001/XMLSchema#string

P698

25057870

http://www.w3.org/2001/XMLSchema#string

P932

4124865

http://www.w3.org/2001/XMLSchema#string